Recent Research Information on Aplastic Anemia, MDS, and PNH

AA&MDSIF strives to keep patients, families, and hematology/oncology professionals up-to-date with developments in research and practice relevant to aplastic anemia, MDS and PNH. Shown below are recent articles from major hematology/oncology journals, retrieved from the National Library of Medicine’s PubMed portal to their MEDLINE database of journal citations and abstracts of the biomedical literature from around the world.


Looking for research oriented for patients and caregivers? For select reviews of important medical journal articles, written by hematology/oncology professionals, visit Research Reviews for Patients. These reviews interpret the most relevant information for patients from the latest published research.

You can also read Research Summaries for Patients that are lay language explanations of scientific meetings and symposia.

Summary information is listed by publication date, title, journal title and senior author. By default, the articles are listed by their publication date in reverse chronological order, from the most recent article to oldest article. Clicking the date column heading will sort them the other way, from oldest to newest.

"Publication date" in most cases means when the article first appeared in the electronic/online issue of a journal, in advance of when it appears in the print journal. Keep in mind some articles may appear online months before appearing in print, and that some may be from online-only journals.

You can also alphabetically and reverse alphabetically sort articles, primary authors and journal titles by clicking their column heading. To find articles by disease type, choose it from the drop-down menu named "Filter by Disease", and only articles about those diseases will appear. The search box labeled “Filter by Search Term” lets you search for a word in the article title, author, or journal name.

When you open an article citation by clicking on the title, article summary information (this time including all authors) is again shown, and in most cases you can view the article abstract. In some cases the abstract is unavailable, and not shown. You can also progress to the article’s PubMed entry by clicking the PubMed ID number link, shown directly under the title. Here you can purchase the article for download viewing or view through your institutional library’s access. In some cases, full text viewing is free either from the publisher’s site or from PubMed Central, an searchable aggregation site of free full text articles.

The PubMed Web site has extensive features, along with help tools and links to other databases. Regular users are encouraged to become familiar with its many capabilities.

Publication Date Article Title Journal Title Primary Authorsort icon Bone Marrow Disease(s)
02/05/2010 Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C. Br J Haematol Fenaux P myelodysplastic syndromes (MDS)
06/06/2014 In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia Haematologica Feng X aplastic anemia
04/26/2012 Decreased plasma cytokines associate with low platelet counts in aplastic anemia and immune thrombocytopenic purpura J Thromb Haemost Feng X
12/15/2010 Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica Feng X aplastic anemia, myelodysplastic syndromes (MDS)
05/01/2010 Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol Fey MF myelodysplastic syndromes (MDS)
07/01/2012 Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes Am J Med Foran JM myelodysplastic syndromes (MDS)
02/17/2012 Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes? Eur J Haematol Fozza C myelodysplastic syndromes (MDS)
12/03/2012 The role of T-cells in the pathogenesis of myelodysplastic syndromes: Passengers and drivers Leuk Res Fozza C myelodysplastic syndromes (MDS)
05/10/2013 The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. Ann Hematol Fu B myelodysplastic syndromes (MDS)
11/01/2013 Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems. Fu B Fu B, Jaso JM, Sargent RL, Goswami M, Verstovsek S, Medeiros myelodysplastic syndromes (MDS)